{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T14:08:32Z","timestamp":1782828512175,"version":"3.54.5"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>Nattokinase (NK) and red yeast rice (RYR) are both indicated for their potential in cardiovascular disease prevention and management, but their combined effects especially in coronary artery disease (CAD) are scarcely examined. This 90-day randomized, double-blind trial aims to investigate the effect of NK and RYR supplementations on cardiometabolic parameters in patients with stable CAD. 178 CAD patients were randomized to four groups: NK\u2009+\u2009RYR, NK, RYR, and placebo. No adverse effects due to the interventions were reported. In comparisons across groups, NK\u2009+\u2009RYR showed the maximum effect in reducing triglyceride (\u22120.39\u2009mmol), total cholesterol (\u22120.66\u2009mmol\/L), diastolic blood pressure (\u22127.39\u2009mmHg), and increase in high-density lipoprotein cholesterol (0.195\u2009mmol\/L) than other groups (all p for multiple groups comparison&amp;lt;0.01). Both NK\u2009+\u2009RYR and NK groups had significantly better-improved lactate dehydrogenase than the others (\u221229.1\u2009U\/L and\u2009\u2212\u200926.4\u2009U\/L). NK\u2009+\u2009RYR group also showed more potent reductions in thromboxane B2 and increases in antithrombin III compared to placebo (both <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.01). These improved markers suggest that combined NK and RYR may preferably alter antithrombin and COX-1 pathways, potentially reducing thrombosis risks in CAD patients. Overall, the combined NK and RYR supplementation is safe and more effective than separately in improving cardiometabolic markers among CAD patients with multiple heart medications use.<\/jats:p>","DOI":"10.3389\/fnut.2024.1380727","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T05:07:51Z","timestamp":1715749671000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Lipid-lowering, antihypertensive, and antithrombotic effects of nattokinase combined with red yeast rice in patients with stable coronary artery disease: a randomized, double-blinded, placebo-controlled trial"],"prefix":"10.3389","volume":"11","author":[{"given":"Man","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhe","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruikun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"8295054","DOI":"10.1155\/2019\/8295054","article-title":"Burden of coronary artery disease and peripheral artery disease: a literature review","volume":"2019","author":"Bauersachs","year":"2019","journal-title":"Cardiovasc Ther"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke Statistics-2021 update: a report from the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the global burden of disease study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3967\/bes2022.079","article-title":"Report on cardiovascular health and diseases in China 2021: an updated summary","volume":"2022","year":"2021","journal-title":"Biomed Environ Sci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3760\/cma.j.issn.0253-3758.2018.02.009","article-title":"A study on the epidemic characteristics of dyslipidemia in adults of nine provinces of China","volume":"46","author":"Dai","year":"2018","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.3760\/cma.j.cn112338-20210508-00379","article-title":"Prevalence and control of hypertension in adults in China, 2018","volume":"42","author":"Zhang","year":"2021","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41569-019-0233-y","article-title":"The myth of \u201cstable\u201d coronary artery disease","volume":"17","author":"Fox","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"16812","DOI":"10.1002\/jcp.28350","article-title":"A review on coronary artery disease, its risk factors, and therapeutics","volume":"234","author":"Malakar","year":"2019","journal-title":"J Cell Physiol"},{"key":"ref9","first-page":"265","article-title":"Guideline for primary care of stable coronary artery disease","volume":"20","year":"2021","journal-title":"Chin J Gen Pract"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.3760\/cma.j.cn112148-20201009-00796","article-title":"Chinese guideline on the primary prevention of cardiovascular diseases","volume":"48","year":"2020","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11739-017-1612-1","article-title":"Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin","volume":"12","author":"Garg","year":"2017","journal-title":"Intern Emerg Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1055\/s-0039-1679104","article-title":"Cardiac biomarkers: what is and what can be","volume":"3","author":"Jacob","year":"2018","journal-title":"Indian J Cardiovasc Dis Women WINCARS"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"FSO251","DOI":"10.4155\/fsoa-2017-0036","article-title":"The role of biomarkers in the diagnosis and risk stratification of acute coronary syndrome","volume":"4","author":"Chacko","year":"2017","journal-title":"Future Sci OA"},{"key":"ref14","article-title":"Thrombosis","volume-title":"StatPearls","author":"Ashorobi","year":"2023"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"117727191878513","DOI":"10.1177\/1177271918785130","article-title":"Nattokinase: a promising alternative in prevention and treatment of cardiovascular diseases","volume":"13","author":"Chen","year":"2018","journal-title":"Biomark Insights"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/ijms18030523","article-title":"Nattokinase: an oral antithrombotic agent for the prevention of cardiovascular disease","volume":"18","author":"Weng","year":"2017","journal-title":"Int J Mol Sci"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.nutres.2009.01.009","article-title":"Nattokinase decreases plasma levels of fibrinogen, factor VII, and factor VIII in human subjects","volume":"29","author":"Hsia","year":"2009","journal-title":"Nutr Res"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1039\/c8fo02324g","article-title":"The effects of nattokinase supplementation on collagen-epinephrine closure time, prothrombin time and activated partial thromboplastin time in nondiabetic and hypercholesterolemic subjects","volume":"10","author":"Yoo","year":"2019","journal-title":"Food Funct"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1021\/jf0117199","article-title":"Antioxidative functions of natto, a kind of fermented soybeans: effect on LDL oxidation and lipid metabolism in cholesterol-fed rats","volume":"50","author":"Iwai","year":"2002","journal-title":"J Agric Food Chem"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1021\/jf011718g","article-title":"Inhibitory effect of natto, a kind of fermented soybeans, on LDL oxidation in vitro","volume":"50","author":"Iwai","year":"2002","journal-title":"J Agric Food Chem"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1291\/hypres.31.1583","article-title":"Effects of nattokinase on blood pressure: a randomized, controlled trial","volume":"31","author":"Kim","year":"2008","journal-title":"Hypertens Res"},{"key":"ref23","first-page":"310","article-title":"Combined nattokinase with red yeast rice but not nattokinase alone has potent effects on blood lipids in human subjects with hyperlipidemia","volume":"18","author":"Yang","year":"2009","journal-title":"Asia Pac J Clin Nutr"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3233\/CH-211147","article-title":"Nattokinase atherothrombotic prevention study: a randomized controlled trial","volume":"78","author":"Hodis","year":"2021","journal-title":"Clin Hemorheol Microcirc"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11883-015-0495-8","article-title":"Red yeast rice for the treatment of dyslipidemia","volume":"17","author":"Burke","year":"2015","journal-title":"Curr Atheroscler Rep"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e98611","DOI":"10.1371\/journal.pone.0098611","article-title":"A meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemia","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"744928","DOI":"10.3389\/fphar.2022.744928","article-title":"Red yeast Rice preparations reduce mortality, major cardiovascular adverse events, and risk factors for metabolic syndrome: a systematic review and Meta\u2212analysis","volume":"13","author":"Yuan","year":"2022","journal-title":"Front Pharmacol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s40795-022-00639-z","article-title":"Evaluation the effects of red yeast rice in combination with statin on lipid profile and inflammatory indices; a randomized clinical trial","volume":"8","author":"Tavan","year":"2022","journal-title":"BMC Nutr"},{"key":"ref29","year":"2020"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"882","DOI":"10.3109\/09637486.2013.809405","article-title":"A combined natural supplement lowers LDL cholesterol in subjects with moderate untreated hypercholesterolemia: a randomized placebo-controlled trial","volume":"64","author":"Barrat","year":"2013","journal-title":"Int J Food Sci Nutr"},{"key":"ref31","year":""},{"key":"ref32","year":"2023"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"4239","DOI":"10.3390\/nu15194239","article-title":"The effect of Nattokinase-Monascus supplements on dyslipidemia: a four-month randomized, double-blind, placebo-controlled clinical trial","volume":"15","author":"Liu","year":"2023","journal-title":"Nutrients"},{"key":"ref34","first-page":"26","article-title":"Lipid-lowering effect of Nattokinase in patients with primary hypercholesterolemia","volume":"25","author":"Wu","year":"2009","journal-title":"Acta Cardiol Sin"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"964977","DOI":"10.3389\/fcvm.2022.964977","article-title":"Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: a clinical study with 1,062 participants","volume":"9","author":"Chen","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"ref36","article-title":"Physiology, clotting mechanism","volume-title":"StatPearls","author":"Garmo","year":"2023"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"11601","DOI":"10.1038\/srep11601","article-title":"A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles","volume":"5","author":"Kurosawa","year":"2015","journal-title":"Sci Rep"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2024.1380727\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T05:08:04Z","timestamp":1715749684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2024.1380727\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,15]]},"references-count":37,"alternative-id":["10.3389\/fnut.2024.1380727"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2024.1380727","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,15]]},"article-number":"1380727"}}